# Filing Detail

Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-25-002214
Filing Date
2025-01-14
Accepted
2025-01-14 17:09:43
Documents
85

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | forms-1.htm iXBRL | S-1 | 3180766
2 |  | ex23-2.htm | EX-23.2 | 3649
3 | CALCULATION OF FILING FEE TABLES | ex107.htm | EX-FILING FEES | 19233
| Complete submission text file | 0001493152-25-002214.txt |  | 12095624

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | envb-20240930.xsd | EX-101.SCH | 81655
5 | XBRL CALCULATION FILE | envb-20240930_cal.xml | EX-101.CAL | 82045
6 | XBRL DEFINITION FILE | envb-20240930_def.xml | EX-101.DEF | 335751
7 | XBRL LABEL FILE | envb-20240930_lab.xml | EX-101.LAB | 631134
8 | XBRL PRESENTATION FILE | envb-20240930_pre.xml | EX-101.PRE | 486808
87 | EXTRACTED XBRL INSTANCE DOCUMENT | forms-1_htm.xml | XML | 2039792

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284277 | Film No.: 25530156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)